Business model

WntResearch is a research company that develops new drugs for treatment of various metastasizing cancer forms.

The company operates in a so-called business-to-business (B2B) model, working to create assets and value in the pre-clinical and clinical settings. The company intends to enter commercial cooperation agreements with one or several major pharmaceutical companies when the time comes to furhter develop and commercialize the company’s drug projects. The company’s executive management is working continously to create and maintain contacts with potential partners.